Medscape InDiscussion: ATTR-CM

About Medscape InDiscussion: ATTR-CM

Listen to Medscape InDiscussion: ATTR-CM, a podcast series where thought leaders and clinical experts share their diverse insights and practical ideas for optimizing patient care. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/ca8/p04/podcast-attr-cm-s1-ep1-2026a10006h9. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

Publisher

Medscape

Category

health & fitness · science

Language

en

Explicit

No

First episode

26 Mar 2026

Latest episode

28 Jul 2026

Latest episodes

6 episodes in the feed.

1. 

   28 Jul 2026

   Choosing Therapies for ATTR-CM in 2026

   Drs Alexander and Urey walk through stabilizers vs silencers, pivotal trial data, and practical first line choices to help you select the right ATTR CM therapy for each patient. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/ca8/p04/podcast-attr-cm-s1-ep6-2026a10006hh (https://www.medscape.com/ca8/p04/podcast-attr-cm-s1-ep6-2026a10006hh). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources Transthyretin-Related Amyloidosis https://emedicine.medscape.com/article/335301-overview (https://emedicine.medscape.com/article/335301-overview) Disease-Modifying Therapies for Amyloid Transthyretin Cardiomyopathy: Current and Emerging Medications https://pubmed.ncbi.nlm.nih.gov/39714070/ (https://pubmed.ncbi.nlm.nih.gov/39714070/) Therapy of Amyloidosis: Stabilizers and Silencers https://pubmed.ncbi.nlm.nih.gov/42099466/ (https://pubmed.ncbi.nlm.nih.gov/42099466/) Tafamidis Treatment for Patients With Transthyretin Amyloid Cardiomyopathy https://pubmed.ncbi.nlm.nih.gov/30145929/ (https://pubmed.ncbi.nlm.nih.gov/30145929/) Efficacy and Safety of Acoramidis in Transthyretin Amyloid Cardiomyopathy https://pubmed.ncbi.nlm.nih.gov/38197816/ (https://pubmed.ncbi.nlm.nih.gov/38197816/) Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy https://pubmed.ncbi.nlm.nih.gov/39213194/ (https://pubmed.ncbi.nlm.nih.gov/39213194/) Diagnostic and Prognostic Value of 99mTc-Pyrophosphate SPECT/CT in Patients With Transthyretin Amyloid Cardiomyopathy https://pubmed.ncbi.nlm.nih.gov/42135510/ (https://pubmed.ncbi.nlm.nih.gov/42135510/) Immunoglobulin-Related Amyloidosis https://emedicine.medscape.com/article/208839-overview (https://emedicine.medscape.com/article/208839-overview) Brain-Type Natriuretic Peptide (BNP) https://emedicine.medscape.com/article/2087425-overview (https://emedicine.medscape.com/article/2087425-overview) The Finkelstein-Schoenfeld Test: A Note on Some Overlooked Issues Concerning Power https://pubmed.ncbi.nlm.nih.gov/38316728/ (https://pubmed.ncbi.nlm.nih.gov/38316728/) The Win Ratio in Cardiology Trials: Lessons Learnt, New Developments, and Wise Future Use https://pubmed.ncbi.nlm.nih.gov/39405050/ (https://pubmed.ncbi.nlm.nih.gov/39405050/) Transthyretin Cardiac Amyloidosis Evaluation and Management: 2025 ACC Concise Clinical Guidance https://pubmed.ncbi.nlm.nih.gov/41171219/ (https://pubmed.ncbi.nlm.nih.gov/41171219/) Disentangling Knots of Misfolded Proteins: Do We Really Know the Prognostic Implications of the Pathogenic V122I TTR Variant https://pubmed.ncbi.nlm.nih.gov/38657853/ (https://pubmed.ncbi.nlm.nih.gov/38657853/) Detecting Polyneuropathy in Patients With Hereditary Transthyretin Amyloid Cardiomyopathy https://pubmed.ncbi.nlm.nih.gov/41732581/ (https://pubmed.ncbi.nlm.nih.gov/41732581/) Futility Monitoring in Clinical Trials https://pubmed.ncbi.nlm.nih.gov/40497544/ (https://pubmed.ncbi.nlm.nih.gov/40497544/) CARDIO-TTRansform: A Study to Evaluate the Efficacy and Safety of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Participants With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM) https://clinicaltrials.gov/study/NCT04136171 (https://clinicaltrials.gov/study/NCT04136171) Transthyretin Cardiac Amyloidosis: Current and Emerging Therapies https://pubmed.ncbi.nlm.nih.gov/39841315/ (https://pubmed.ncbi.nlm.nih.gov/39841315/) Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com (https://pcm.adswizz.com) for information about our collection and use of personal data for advertising.

2. 

   30 Jun 2026

   How Many ATTR-CM Patients Are We Still Missing?

   From missed red flags to insurance denials, the barriers to ATTR-CM care are multi-level. Drs Alexander and Pino-Moreno break down what’s failing and how to fix it. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/ca8/p04/podcast-attr-cm-s1-ep5-2026a10006hg (https://www.medscape.com/ca8/p04/podcast-attr-cm-s1-ep5-2026a10006hg). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources: Transthyretin-Related Amyloidosis https://emedicine.medscape.com/article/335301-overview (https://emedicine.medscape.com/article/335301-overview) Overview of Barriers to Healthcare Access: Medical Deserts and Individual Sandboxes https://pubmed.ncbi.nlm.nih.gov/40814546/ (https://pubmed.ncbi.nlm.nih.gov/40814546/) The Impact of Social Determinants of Health on Timely Detection in Transthyretin Cardiac Amyloidosis https://pubmed.ncbi.nlm.nih.gov/40044389/ (https://pubmed.ncbi.nlm.nih.gov/40044389/) Is There a Connection Between Social Deprivation and Severity of Newly Diagnosed Transthyretin Cardiac Amyloidosis in Hawaii? https://onlinejcf.com/article/S1071-9164(25)00800-0/abstract (https://onlinejcf.com/article/S1071-9164(25)00800-0/abstract) 99mTc Bone-Avid Tracer Cardiac Scintigraphy: Role in Noninvasive Diagnosis of Transthyretin Cardiac Amyloidosis https://pubmed.ncbi.nlm.nih.gov/36537896/ (https://pubmed.ncbi.nlm.nih.gov/36537896/) Cardiac Amyloidosis Red Flags: What All Cardiologists Have to Know https://pubmed.ncbi.nlm.nih.gov/39118988/ (https://pubmed.ncbi.nlm.nih.gov/39118988/) Carpal Tunnel Syndrome as a Potential Indicator of Cardiac Amyloidosis: A Systematic Review and Meta-Analysis https://pubmed.ncbi.nlm.nih.gov/39691410/ (https://pubmed.ncbi.nlm.nih.gov/39691410/) Clinical Clues and Diagnostic Workup of Cardiac Amyloidosis https://pubmed.ncbi.nlm.nih.gov/35414856/ (https://pubmed.ncbi.nlm.nih.gov/35414856/) Diagnosing AL and ATTR Amyloid Cardiomyopathy: A Multidisciplinary Approach https://pubmed.ncbi.nlm.nih.gov/39407933/ (https://pubmed.ncbi.nlm.nih.gov/39407933/) Tafamidis Treatment for Patients With Transthyretin Amyloid Cardiomyopathy https://pubmed.ncbi.nlm.nih.gov/30145929/ (https://pubmed.ncbi.nlm.nih.gov/30145929/) Efficacy and Safety of Acoramidis in Transthyretin Amyloid Cardiomyopathy https://pubmed.ncbi.nlm.nih.gov/38197816/ (https://pubmed.ncbi.nlm.nih.gov/38197816/) Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy https://pubmed.ncbi.nlm.nih.gov/39213194/ (https://pubmed.ncbi.nlm.nih.gov/39213194/) Best Practices and Key Barriers for Amyloidosis Patient Care at US Specialized Amyloidosis Centers: An Analysis by ARC-ASPIRE https://pubmed.ncbi.nlm.nih.gov/42077643/ (https://pubmed.ncbi.nlm.nih.gov/42077643/) Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com (https://pcm.adswizz.com) for information about our collection and use of personal data for advertising.

3. 

   28 May 2026

   Managing Heart Failure in ATTR-CM

   From narrow volume windows to SGLT2 inhibitors and emerging devices, Drs Kevin Alexander and Sarah Cuddy discuss heart failure care in ATTR-CM. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/ca8/p04/podcast-attr-cm-s1-ep4-2026a10006he (https://www.medscape.com/ca8/p04/podcast-attr-cm-s1-ep4-2026a10006he). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources Transthyretin-Related Amyloidosis https://emedicine.medscape.com/article/335301-overview (https://emedicine.medscape.com/article/335301-overview) Diversity of Heart Failure Phenotypes in Transthyretin Amyloid Cardiomyopathy. More Than Just Heart Failure With Preserved Ejection Fraction https://pubmed.ncbi.nlm.nih.gov/39460551/ (https://pubmed.ncbi.nlm.nih.gov/39460551/) Transthyretin Amyloid Cardiomyopathy: The Plot Thickens as Novel Therapies Emerge https://pubmed.ncbi.nlm.nih.gov/41210313/ (https://pubmed.ncbi.nlm.nih.gov/41210313/) The Role of SGLT2-Inhibitors Across All Stages of Heart Failure and Mechanisms of Early Clinical Benefit: From Prevention to Advanced Heart Failure https://pubmed.ncbi.nlm.nih.gov/40149587/ (https://pubmed.ncbi.nlm.nih.gov/40149587/) Mineralocorticoid Receptor Antagonists in Heart Failure: An Update https://pubmed.ncbi.nlm.nih.gov/39584253/ (https://pubmed.ncbi.nlm.nih.gov/39584253/) Primary Systemic Amyloidosis https://emedicine.medscape.com/article/1093258-overview (https://emedicine.medscape.com/article/1093258-overview) Guideline-Directed Medical Therapy Intolerance in Heart Failure https://pubmed.ncbi.nlm.nih.gov/39466259/ (https://pubmed.ncbi.nlm.nih.gov/39466259/) Conventional Heart Failure Therapy in Cardiac ATTR Amyloidosis https://pubmed.ncbi.nlm.nih.gov/37216684/ (https://pubmed.ncbi.nlm.nih.gov/37216684/) Device Therapies for Heart Failure With Reduced Ejection Fraction: A New Era https://pubmed.ncbi.nlm.nih.gov/39494238/ (https://pubmed.ncbi.nlm.nih.gov/39494238/) CardioMEMS Heart Failure System: An Up-to-Date Review https://pubmed.ncbi.nlm.nih.gov/39991420/ (https://pubmed.ncbi.nlm.nih.gov/39991420/) Mechanisms of Chronotropic Incompetence in Heart Failure With Preserved Ejection Fraction https://pubmed.ncbi.nlm.nih.gov/32164435/ (https://pubmed.ncbi.nlm.nih.gov/32164435/) Cardiac Resynchronization Therapy https://www.ncbi.nlm.nih.gov/books/NBK567773/ (https://www.ncbi.nlm.nih.gov/books/NBK567773/) Kidney Outcomes in Transthyretin Amyloid Cardiomyopathy https://pubmed.ncbi.nlm.nih.gov/39550765/ (https://pubmed.ncbi.nlm.nih.gov/39550765/) Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com (https://pcm.adswizz.com) for information about our collection and use of personal data for advertising.

4. 

   28 Apr 2026

   Don't Miss the Zebra: AI in ATTR-CM

   ATTR-CM is the zebra hiding among the horses. AI may finally be the tool that finds it. Experts Drs Kevin Alexander and Lily Stern explore what's working, what's not, and what comes next. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/ca8/p04/podcast-attr-cm-s1-ep3-2026a10006hb (https://www.medscape.com/ca8/p04/podcast-attr-cm-s1-ep3-2026a10006hb). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources Transthyretin-Related Amyloidosis https://emedicine.medscape.com/article/335301-overview (https://emedicine.medscape.com/article/335301-overview) The Role of Artificial Intelligence in Cardiac Amyloidosis: A Focus on Diagnosis and Clinical Application https://pubmed.ncbi.nlm.nih.gov/40558656/ (https://pubmed.ncbi.nlm.nih.gov/40558656/) Concordance of Left Ventricular Volumes and Function Measurements Between Two Human Readers, a Fully Automated AI Algorithm, and the 3D Heart Model https://pubmed.ncbi.nlm.nih.gov/39081366/ (https://pubmed.ncbi.nlm.nih.gov/39081366/) High-Throughput Precision Phenotyping of Left Ventricular Hypertrophy With Cardiovascular Deep Learning https://pubmed.ncbi.nlm.nih.gov/35195663/ (https://pubmed.ncbi.nlm.nih.gov/35195663/) Eplontersen for Hereditary Transthyretin Amyloidosis With Polyneuropathy https://pubmed.ncbi.nlm.nih.gov/37768671/ (https://pubmed.ncbi.nlm.nih.gov/37768671/) Diagnosing AL and ATTR Amyloid Cardiomyopathy: A Multidisciplinary Approach https://pubmed.ncbi.nlm.nih.gov/39407933/ (https://pubmed.ncbi.nlm.nih.gov/39407933/) Advances in Imaging-Based Diagnosis, Prognosis, and Response Assessment in Cardiac Amyloidosis: A Comprehensive Multimodality Review https://pmc.ncbi.nlm.nih.gov/articles/PMC12450123/ (https://pmc.ncbi.nlm.nih.gov/articles/PMC12450123/) Exploring the Utility of Carpal Tunnel Biopsy in Amyloidosis: A Current Perspective https://pubmed.ncbi.nlm.nih.gov/39588898/ (https://pubmed.ncbi.nlm.nih.gov/39588898/) Design and Rationale the SCAN-MP (Screening for Cardiac Amyloidosis With Nuclear Imaging in Minority Populations) Study https://pubmed.ncbi.nlm.nih.gov/37066788/ (https://pubmed.ncbi.nlm.nih.gov/37066788/) Artificial Intelligence-Enhanced Electrocardiogram for the Early Detection of Cardiac Amyloidosis https://pubmed.ncbi.nlm.nih.gov/34218880/ (https://pubmed.ncbi.nlm.nih.gov/34218880/) Machine Learning-Based CT Angiography-Derived Fractional Flow Reserve for Diagnosis of Functionally Significant Coronary Artery Disease https://pubmed.ncbi.nlm.nih.gov/36889853/ (https://pubmed.ncbi.nlm.nih.gov/36889853/) NYHA Classification for Decision-Making in Heart Failure: Time to Reassess? https://pubmed.ncbi.nlm.nih.gov/37264724/ (https://pubmed.ncbi.nlm.nih.gov/37264724/) Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com (https://pcm.adswizz.com) for information about our collection and use of personal data for advertising.

5. 

   26 Mar 2026

   Can Early Genetic Testing Change ATTR-CM Outcomes?

   Drs Kevin Alexander and Joban Vaishnav explore when and how to use genetic testing in ATTR-CM, why distinguishing hereditary from wild-type disease matters, and what this means for patients' families. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/ca8/p04/podcast-attr-cm-s1-ep2-2026a10006ha (https://www.medscape.com/ca8/p04/podcast-attr-cm-s1-ep2-2026a10006ha). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources Transthyretin-Related Amyloidosis https://emedicine.medscape.com/article/335301-overview (https://emedicine.medscape.com/article/335301-overview) Tafamidis Treatment for Patients With Transthyretin Amyloid Cardiomyopathy https://pubmed.ncbi.nlm.nih.gov/30145929/ (https://pubmed.ncbi.nlm.nih.gov/30145929/) Molecular Mechanisms and Emerging Therapies in Wild-Type Transthyretin Amyloid Cardiomyopathy https://pubmed.ncbi.nlm.nih.gov/38233673/ (https://pubmed.ncbi.nlm.nih.gov/38233673/) Hereditary Transthyretin Amyloidosis (ATTRv) https://pubmed.ncbi.nlm.nih.gov/39954876/ (https://pubmed.ncbi.nlm.nih.gov/39954876/) 99mTc Bone-Avid Tracer Cardiac Scintigraphy: Role in Noninvasive Diagnosis of Transthyretin Cardiac Amyloidosis https://pubmed.ncbi.nlm.nih.gov/36537896/ (https://pubmed.ncbi.nlm.nih.gov/36537896/) Utility of Genetic Testing in Patients With Transthyretin Amyloid Cardiomyopathy: A Brief Review https://pubmed.ncbi.nlm.nih.gov/38275387/ (https://pubmed.ncbi.nlm.nih.gov/38275387/) Clinical Comparison of V122I Genotypic Variant of Transthyretin Amyloid Cardiomyopathy With Wild-Type and Other Hereditary Variants: A Systematic Review https://pubmed.ncbi.nlm.nih.gov/33768376/ (https://pubmed.ncbi.nlm.nih.gov/33768376/) V122I TTR Cardiac Amyloidosis in Patients of African Descent: Recognizing a Missed Disease or the Dog That Didn't Bark?https://pubmed.ncbi.nlm.nih.gov/27618856/ (https://pubmed.ncbi.nlm.nih.gov/27618856/) Genetic and Clinical Features of Hereditary Transthyretin Amyloidosis: A Decade of Experience at a Japanese Referral Center https://pubmed.ncbi.nlm.nih.gov/40898332/ (https://pubmed.ncbi.nlm.nih.gov/40898332/) Effectiveness and Utility of Genetic Testing in Establishing a Diagnosis of Hereditary Transthyretin Amyloidosis https://pubmed.ncbi.nlm.nih.gov/41095902/ (https://pubmed.ncbi.nlm.nih.gov/41095902/) Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant https://clinicaltrials.gov/study/NCT06563895 (https://clinicaltrials.gov/study/NCT06563895) Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com (https://pcm.adswizz.com) for information about our collection and use of personal data for advertising.

6. 

   26 Mar 2026

   Rethinking Rhythm Control in ATTR-CM

   Is rhythm control underused in ATTR-CM? Drs Kevin Alexander and Ronald Witteles make the case for rethinking how we manage arrhythmias in this disease. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/ca8/p04/podcast-attr-cm-s1-ep1-2026a10006h9 (https://www.medscape.com/ca8/p04/podcast-attr-cm-s1-ep1-2026a10006h9). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources Transthyretin-Related Amyloidosis https://emedicine.medscape.com/article/335301-overview (https://emedicine.medscape.com/article/335301-overview) Primary Systemic Amyloidosis https://emedicine.medscape.com/article/1093258-overview (https://emedicine.medscape.com/article/1093258-overview) Arrhythmias in Patients With Cardiac Amyloidosis: A Comprehensive Review on Clinical Management and Devices https://pubmed.ncbi.nlm.nih.gov/37623350/ (https://pubmed.ncbi.nlm.nih.gov/37623350/) Atrial Fibrillation in the Setting of Cardiac Amyloidosis - A Review of the Literature https://pubmed.ncbi.nlm.nih.gov/38565394/ (https://pubmed.ncbi.nlm.nih.gov/38565394/) Atrial Fibrillation/Flutter in Transthyretin Cardiac Amyloidosis: Prevalence, Incidence, Clinical Predictors, and Effect of Tafamidis https://pubmed.ncbi.nlm.nih.gov/41448121/ (https://pubmed.ncbi.nlm.nih.gov/41448121/) Disease-Modifying Therapies in Transthyretin Amyloid Cardiomyopathy: What Have We Achieved https://pubmed.ncbi.nlm.nih.gov/41698526/ (https://pubmed.ncbi.nlm.nih.gov/41698526/) SGLT2 Inhibitor Therapy in Patients With Transthyretin Amyloid Cardiomyopathy https://pubmed.ncbi.nlm.nih.gov/38866445/ (https://pubmed.ncbi.nlm.nih.gov/38866445/) Direct Oral Anticoagulants in Patients With Cardiac Amyloidosis: A Systematic Review and Meta-analysis https://pubmed.ncbi.nlm.nih.gov/38303916/ (https://pubmed.ncbi.nlm.nih.gov/38303916/) Pulsed Field Ablation of Atrial Fibrillation: A Comprehensive Review https://pubmed.ncbi.nlm.nih.gov/39076426/ (https://pubmed.ncbi.nlm.nih.gov/39076426/) Transthyretin Cardiac Amyloidosis Evaluation and Management: 2025 ACC Concise Clinical Guidance https://pubmed.ncbi.nlm.nih.gov/41171219/ (https://pubmed.ncbi.nlm.nih.gov/41171219/) 99m Technetium-Pyrophosphate Scintigraphy: A Practical Guide for Early Diagnosis of Transthyretin Amyloid Cardiomyopathy https://pubmed.ncbi.nlm.nih.gov/34841715/ (https://pubmed.ncbi.nlm.nih.gov/34841715/) Biomarkers in Heart Failure: A Review and a Wish https://pubmed.ncbi.nlm.nih.gov/40869365/ (https://pubmed.ncbi.nlm.nih.gov/40869365/) Tafamidis Treatment for Patients With Transthyretin Amyloid Cardiomyopathy https://pubmed.ncbi.nlm.nih.gov/30145929/ (https://pubmed.ncbi.nlm.nih.gov/30145929/) Safety of Direct Current Cardioversion Without Routine Transesophageal Echocardiography in Patients With Cardiac Amyloidosis https://pubmed.ncbi.nlm.nih.gov/39111975/ (https://pubmed.ncbi.nlm.nih.gov/39111975/) Efficacy and Safety of Acoramidis in Transthyretin Amyloid Cardiomyopathy https://pubmed.ncbi.nlm.nih.gov/38197816/ (https://pubmed.ncbi.nlm.nih.gov/38197816/) Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy https://pubmed.ncbi.nlm.nih.gov/39213194/ (https://pubmed.ncbi.nlm.nih.gov/39213194/) CARDIO-TTRansform: A Study to Evaluate the Efficacy and Safety of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Participants With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM) https://clinicaltrials.gov/study/NCT04136171 (https://clinicaltrials.gov/study/NCT04136171) Prevalence and Functional Impact of Chronotropic Incompetence in Amyloid Cardiomyopathy: A Multicentre Analysis https://pubmed.ncbi.nlm.nih.gov/39794925/ (https://pubmed.ncbi.nlm.nih.gov/39794925/) Cardiac Resynchronization Therapy: Current Guidelines and Recent Advances Beyond Drug Treatment https://pubmed.ncbi.nlm.nih.gov/37246328/ (https://pubmed.ncbi.nlm.nih.gov/37246328/) Percutaneous Left Atrial Appendage Closure With the Watchman Device: A Systematic Review https://pubmed.ncbi.nlm.nih.gov/38616940/ (https://pubmed.ncbi.nlm.nih.gov/38616940/) Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com (https://pcm.adswizz.com) for information about our collection and use of personal data for advertising.

Contact Medscape InDiscussion: ATTR-CM

Guest appearances

Books guests

Based on episode analysis; this does not confirm that the show is currently accepting guests.